Hiroko Masamune

Catalytic asymmetric epoxidation and kinetic resolution: modified procedures including in situ derivatization

Yun Gao, Janice M. Klunder, Robert M. Hanson et al. · Journal of the American Chemical Society · 1987 · 1.9K citations

Natural Sciences, Biochemistry, Chemistry +15

Biarylcarboxylic Acids and -amides:  Inhibition of Phosphodiesterase Type IV versus [³H]Rolipram Binding Activity and Their Relationship to Emetic Behavior in the Ferret

Allen J. Duplantier, Michael S. Biggers, Robert Chambers et al. · Journal of Medicinal Chemistry · 1996 · 143 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

LBP-20-VK2809, a Novel Liver-Directed Thyroid Receptor Beta Agonist, Significantly Reduces Liver Fat with Both Low and High Doses in Patients with Non-Alcoholic Fatty Liver Disease: A Phase 2 Randomized, Placebo-Controlled Trial

Rohit Loomba, Joel Neutel, Rizwana Mohseni et al. · Journal of Hepatology · 2019 · 85 citations

Pharmacy, Pharmacology, Pharmacotherapy +12

A Liver-Specific Thyromimetic, VK2809, Decreases Hepatosteatosis in Glycogen Storage Disease Type Ia

Jin Zhou, Lauren R. Waskowicz, Andrea Lim et al. · Thyroid · 2019 · 61 citations · Full text

Life Sciences, Endocrinology, Pathology +17

3‘-Aminoadenosine-5‘-uronamides:  Discovery of the First Highly Selective Agonist at the Human Adenosine A ₃ Receptor

Michael P. DeNinno, Hiroko Masamune, Lois K. Chenard et al. · Journal of Medicinal Chemistry · 2002 · 59 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14